164 related articles for article (PubMed ID: 30112379)
1. The Impact of Artesunate-Amodiaquine on Schistosoma mansoni Infection among Children Infected by Plasmodium in Rural Area of Lemfu, Kongo Central, Democratic Republic of the Congo.
Mbanzulu KM; Zanga JK; Mukendi JPK; Mbaya Ntita F; Matangila JR; Muhindo HM; Mpoyi Wa Mpoyi S; Aloni MN; Wumba R
Biomed Res Int; 2018; 2018():3487183. PubMed ID: 30112379
[TBL] [Abstract][Full Text] [Related]
2. Artesunate + amodiaquine and artesunate + sulphadoxine-pyrimethamine for treatment of uncomplicated malaria in Democratic Republic of Congo: a clinical trial with determination of sulphadoxine and pyrimethamine-resistant haplotypes.
Swarthout TD; van den Broek IV; Kayembe G; Montgomery J; Pota H; Roper C
Trop Med Int Health; 2006 Oct; 11(10):1503-11. PubMed ID: 17002724
[TBL] [Abstract][Full Text] [Related]
3. Plasmodium falciparum and Schistosoma mansoni coinfection and the side benefit of artemether-lumefantrine in malaria patients.
Abay SM; Tilahun M; Fikrie N; Habtewold A
J Infect Dev Ctries; 2013 Jun; 7(6):468-74. PubMed ID: 23771290
[TBL] [Abstract][Full Text] [Related]
4. Varying efficacy of artesunate+amodiaquine and artesunate+sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in the Democratic Republic of Congo: a report of two in-vivo studies.
Bonnet M; Broek Iv; van Herp M; Urrutia PP; van Overmeir C; Kyomuhendo J; Ndosimao CN; Ashley E; Guthmann JP
Malar J; 2009 Aug; 8():192. PubMed ID: 19664280
[TBL] [Abstract][Full Text] [Related]
5. In vivo/ex vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso.
Lingani M; Bonkian LN; Yerbanga I; Kazienga A; Valéa I; Sorgho H; Ouédraogo JB; Mens PF; Schallig HDFH; Ravinetto R; d'Alessandro U; Tinto H
Malar J; 2020 Jan; 19(1):8. PubMed ID: 31906948
[TBL] [Abstract][Full Text] [Related]
6. The antischistosomal efficacies of artesunate-sulfamethoxypyrazine-pyrimethamine and artemether-lumefantrine administered as treatment for uncomplicated, Plasmodium falciparum malaria.
Adam I; Elhardello OA; Elhadi MO; Abdalla E; Elmardi KA; Jansen FH
Ann Trop Med Parasitol; 2008 Jan; 102(1):39-44. PubMed ID: 18186976
[TBL] [Abstract][Full Text] [Related]
7. Monitoring of efficacy, tolerability and safety of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Lambaréné, Gabon: an open-label clinical trial.
Adegbite BR; Edoa JR; Honkpehedji YJ; Zinsou FJ; Dejon-Agobe JC; Mbong-Ngwese M; Lotola-Mougueni F; Koehne E; Lalremruata A; Kreidenweiss A; Nguyen TT; Kun J; Agnandji ST; Lell B; Safiou AR; Obone Atome FA; Mombo-Ngoma G; Ramharter M; Velavan TP; Mordmüller B; Kremsner PG; Adegnika AA
Malar J; 2019 Dec; 18(1):424. PubMed ID: 31842893
[TBL] [Abstract][Full Text] [Related]
8. Co-infection of Plasmodium falciparum and Schistosoma mansoni is associated with anaemia.
Dassah SD; Nyaah KE; Senoo DKJ; Ziem JB; Aniweh Y; Amenga-Etego L; Awandare GA; Abugri J
Malar J; 2023 Sep; 22(1):272. PubMed ID: 37710279
[TBL] [Abstract][Full Text] [Related]
9. Randomized, multicentre assessment of the efficacy and safety of ASAQ--a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria.
Ndiaye JL; Randrianarivelojosia M; Sagara I; Brasseur P; Ndiaye I; Faye B; Randrianasolo L; Ratsimbasoa A; Forlemu D; Moor VA; Traore A; Dicko Y; Dara N; Lameyre V; Diallo M; Djimde A; Same-Ekobo A; Gaye O
Malar J; 2009 Jun; 8():125. PubMed ID: 19505304
[TBL] [Abstract][Full Text] [Related]
10. In vivo efficacy of artesunate-amodiaquine and artemether-lumefantrine for the treatment of uncomplicated falciparum malaria: an open-randomized, non-inferiority clinical trial in South Kivu, Democratic Republic of Congo.
de Wit M; Funk AL; Moussally K; Nkuba DA; Siddiqui R; Bil K; Piriou E; Bart A; Bahizi Bizoza P; Bousema T
Malar J; 2016 Sep; 15(1):455. PubMed ID: 27599612
[TBL] [Abstract][Full Text] [Related]
11. Molecular surveillance of anti-malarial drug resistance in Democratic Republic of Congo: high variability of chloroquinoresistance and lack of amodiaquinoresistance.
Yobi DM; Kayiba NK; Mvumbi DM; Boreux R; Kabututu PZ; Situakibanza HNT; Likwela JL; De Mol P; Okitolonda EW; Speybroeck N; Mvumbi GL; Hayette MP
Malar J; 2020 Mar; 19(1):121. PubMed ID: 32197607
[TBL] [Abstract][Full Text] [Related]
12. Artemisinin-based combinations versus amodiaquine plus sulphadoxine-pyrimethamine for the treatment of uncomplicated malaria in Faladje, Mali.
Kayentao K; Maiga H; Newman RD; McMorrow ML; Hoppe A; Yattara O; Traore H; Kone Y; Guirou EA; Saye R; Traore B; Djimde A; Doumbo OK
Malar J; 2009 Jan; 8():5. PubMed ID: 19128455
[TBL] [Abstract][Full Text] [Related]
13. Safety and tolerability of artesunate-amodiaquine, artemether-lumefantrine and quinine plus clindamycin in the treatment of uncomplicated Plasmodium falciparum malaria in Kinshasa, the Democratic Republic of the Congo.
Lula Ntamba Y; Muhindo Mavoko H; Kalabuanga M; Fungula B; Ntamabyaliro Nsengi PM; Tona Lutete G; Inocencio da Luz R; Van Geertruyden JP; Lutumba P
PLoS One; 2019; 14(9):e0222379. PubMed ID: 31527899
[TBL] [Abstract][Full Text] [Related]
14. The efficacy and safety of a new fixed-dose combination of amodiaquine and artesunate in young African children with acute uncomplicated Plasmodium falciparum.
Sirima SB; Tiono AB; Gansané A; Diarra A; Ouédraogo A; Konaté AT; Kiechel JR; Morgan CC; Olliaro PL; Taylor WR
Malar J; 2009 Mar; 8():48. PubMed ID: 19291301
[TBL] [Abstract][Full Text] [Related]
15. The duration of chemoprophylaxis against malaria after treatment with artesunate-amodiaquine and artemether-lumefantrine and the effects of pfmdr1 86Y and pfcrt 76T: a meta-analysis of individual patient data.
Bretscher MT; Dahal P; Griffin J; Stepniewska K; Bassat Q; Baudin E; D'Alessandro U; Djimde AA; Dorsey G; Espié E; Fofana B; González R; Juma E; Karema C; Lasry E; Lell B; Lima N; Menéndez C; Mombo-Ngoma G; Moreira C; Nikiema F; Ouédraogo JB; Staedke SG; Tinto H; Valea I; Yeka A; Ghani AC; Guerin PJ; Okell LC
BMC Med; 2020 Feb; 18(1):47. PubMed ID: 32098634
[TBL] [Abstract][Full Text] [Related]
16. Uncomplicated Clinical Malaria Features, the Efficacy of Artesunate-Amodiaquine and Their Relation with Multiplicity of Infection in the Democratic Republic of Congo.
Muhindo Mavoko H; Kalabuanga M; Delgado-Ratto C; Maketa V; Mukele R; Fungula B; Inocêncio da Luz R; Rosanas-Urgell A; Lutumba P; Van Geertruyden JP
PLoS One; 2016; 11(6):e0157074. PubMed ID: 27280792
[TBL] [Abstract][Full Text] [Related]
17. Amodiaquine-artesunate vs artemether-lumefantrine for uncomplicated malaria in Ghanaian children: a randomized efficacy and safety trial with one year follow-up.
Adjei GO; Kurtzhals JA; Rodrigues OP; Alifrangis M; Hoegberg LC; Kitcher ED; Badoe EV; Lamptey R; Goka BQ
Malar J; 2008 Jul; 7():127. PubMed ID: 18620577
[TBL] [Abstract][Full Text] [Related]
18. Non-typhoidal Salmonella intestinal carriage in a Schistosoma mansoni endemic community in a rural area of the Democratic Republic of Congo.
Mbuyi-Kalonji L; Barbé B; Nkoji G; Madinga J; Roucher C; Linsuke S; Hermy M; Heroes AS; Mattheus W; Polman K; Lutumba P; Phoba MF; Lunguya O; Jacobs J
PLoS Negl Trop Dis; 2020 Feb; 14(2):e0007875. PubMed ID: 32084128
[TBL] [Abstract][Full Text] [Related]
19. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
[TBL] [Abstract][Full Text] [Related]
20. In vivo efficacy and safety of artemether-lumefantrine and amodiaquine-artesunate for uncomplicated Plasmodium falciparum malaria in Mozambique, 2018.
Nhama A; Nhamússua L; Macete E; Bassat Q; Salvador C; Enosse S; Candrinho B; Carvalho E; Nhacolo A; Chidimatembue A; Saifodine A; Zulliger R; Lucchi N; Svigel SS; Moriarty LF; Halsey ES; Mayor A; Aide P
Malar J; 2021 Oct; 20(1):390. PubMed ID: 34600544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
